Stock Analysis

We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

JSE:APN
Source: Shutterstock

The subdued stock price reaction suggests that Aspen Pharmacare Holdings Limited's (JSE:APN) strong earnings didn't offer any surprises. Investors are probably missing some underlying factors which are encouraging for the future of the company.

See our latest analysis for Aspen Pharmacare Holdings

earnings-and-revenue-history
JSE:APN Earnings and Revenue History October 12th 2021

How Do Unusual Items Influence Profit?

To properly understand Aspen Pharmacare Holdings' profit results, we need to consider the R1.2b expense attributed to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. If Aspen Pharmacare Holdings doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Aspen Pharmacare Holdings' Profit Performance

Unusual items (expenses) detracted from Aspen Pharmacare Holdings' earnings over the last year, but we might see an improvement next year. Because of this, we think Aspen Pharmacare Holdings' earnings potential is at least as good as it seems, and maybe even better! And on top of that, its earnings per share increased by 42% in the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you'd like to know more about Aspen Pharmacare Holdings as a business, it's important to be aware of any risks it's facing. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of Aspen Pharmacare Holdings.

Today we've zoomed in on a single data point to better understand the nature of Aspen Pharmacare Holdings' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

Valuation is complex, but we're helping make it simple.

Find out whether Aspen Pharmacare Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.